Compare $ELUT vs $MGX | Chartloom

Compare

$ELUT vs $MGX

Elutia Inc · Metagenomi Therapeutics Inc

ELUT

Elutia Inc

MGX

Metagenomi Therapeutics Inc

Compare $ELUT vs $MGX

Comparing Elutia Inc and Metagenomi Therapeutics Inc

ELUTElutia Inc

MGXMetagenomi Therapeutics Inc

ELUTElutia Inc

Market cap

$36M

P/E (TTM)

0.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-48.8%

YTD performance

28.0%

52W performance

-7.4%

FCF yield

-126.5%

MGXMetagenomi Therapeutics Inc

Market cap

$38M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

-50.7%

YTD performance

-40.1%

52W performance

-68.7%

FCF yield

-227.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELUT

MGX

Detailed metrics comparison

ELUT

Elutia Inc

MGX

Metagenomi Therapeutics Inc

Market Cap

ELUT$36M

MGX$38M

Enterprise Value

ELUT$16M

MGX$-1M

Price

ELUT$0.82

MGX$1.00

P/E Ratio

ELUT0.70x

MGXN/A

P/S Ratio

ELUT3.00x

MGX2.72x

EV/Sales

ELUT1.36x

MGX-0.10x

EV/EBITDA

ELUT0.00x

MGX0.00x

P/B Ratio

ELUT2.19x

MGX0.34x

P/FCF Ratio

ELUTN/A

MGXN/A

EV/FCF

ELUT-0.36x

MGX0.02x

PEG Ratio

ELUTN/A

MGXN/A

Forward P/E (NTM)

ELUTN/A

MGXN/A

Forward P/S (NTM)

ELUTN/A

MGX3.83x

Revenue (TTM)

ELUT$12M

MGX$14M

Revenue Growth (YoY)

ELUT-48.8%

MGX-50.7%

Forward Rev Growth

ELUT-42.7%

MGX30.0%

Gross Margin (TTM)

ELUT57.8%

MGX0.0%

Operating Margin (TTM)

ELUT0.0%

MGX0.0%

EBITDA Margin (TTM)

ELUT-163.0%

MGX-491.3%

Net Margin (TTM)

ELUT426.9%

MGX-477.5%

FCF Margin (TTM)

ELUT-379.3%

MGX-620.9%

Net Income (TTM)

ELUT$52M

MGX$-66M

FCF (TTM)

ELUT$-46M

MGX$-86M

EPS (TTM)

ELUT$1.17

MGX$0.00

ROE (TTM)

ELUT253.3%

MGX-5123.0%

ROA (TTM)

ELUT108.7%

MGX-3662.0%

ROIC (TTM)

ELUT253.3%

MGX-5123.0%

Cash

ELUT$20M

MGX$39M

Debt

ELUT$0

MGX$0

Net Cash/Debt

ELUT$20M

MGX$39M

Current Ratio (TTM)

ELUT1.77x

MGX4.50x

Quick Ratio (TTM)

ELUT1.58x

MGX4.37x

Debt/Equity (TTM)

ELUT0.00x

MGX0.00x

Debt/Assets (TTM)

ELUT0.0%

MGX0.0%

Interest Coverage (TTM)

ELUTN/A

MGXN/A

Net Debt/EBITDA (TTM)

ELUT0.00x

MGX0.00x

Beta

ELUT0.97

MGX0.68

52W Performance

ELUT-7.4%

MGX-68.7%

YTD Performance

ELUT28.0%

MGX-40.1%

% from 52W High

ELUT-40.6%

MGX-74.7%

% from 52W Low

ELUT64.6%

MGX4.2%

Asset Turnover (TTM)

ELUT0.25x

MGX0.10x

FCF Yield (TTM)

ELUT-126.5%

MGX-227.9%

Earnings Yield (TTM)

ELUT142.4%

MGX-175.2%

Dividend Yield (TTM)

ELUTN/A

MGXN/A

Rule of 40

ELUT-428.1

MGX-671.6

EV/GP/RG

ELUTN/A

MGXN/A

Ticker research

View ELUT research View MGX research

Metric	ELUT Elutia Inc	MGX Metagenomi Therapeutics Inc
Market & Valuation
Market Cap	$36M	$38M
Enterprise Value	$16M	$-1M
Price	$0.82	$1.00
P/E Ratio	0.70x	N/A
P/S Ratio	3.00x	2.72x
EV/Sales	1.36x	-0.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.19x	0.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.36x	0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.83x
Revenue & Growth
Revenue (TTM)	$12M	$14M
Revenue Growth (YoY)	-48.8%	-50.7%
Forward Rev Growth	-42.7%	30.0%
Profitability
Gross Margin (TTM)	57.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-163.0%	-491.3%
Net Margin (TTM)	426.9%	-477.5%
FCF Margin (TTM)	-379.3%	-620.9%
Net Income (TTM)	$52M	$-66M
FCF (TTM)	$-46M	$-86M
EPS (TTM)	$1.17	$0.00
ROE (TTM)	253.3%	-5123.0%
ROA (TTM)	108.7%	-3662.0%
ROIC (TTM)	253.3%	-5123.0%
Financial Health
Cash	$20M	$39M
Debt	$0	$0
Net Cash/Debt	$20M	$39M
Current Ratio (TTM)	1.77x	4.50x
Quick Ratio (TTM)	1.58x	4.37x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	0.68
52W Performance	-7.4%	-68.7%
YTD Performance	28.0%	-40.1%
% from 52W High	-40.6%	-74.7%
% from 52W Low	64.6%	4.2%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.10x
FCF Yield (TTM)	-126.5%	-227.9%
Earnings Yield (TTM)	142.4%	-175.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-428.1	-671.6
EV/GP/RG	N/A	N/A
Ticker research	View ELUT research	View MGX research

Valuation

P/E Ratio

ELUT

0.70x

P/S Ratio

MGX

2.72x

ELUT

3.00x

EV/FCF

ELUT

-0.36x

MGX

0.02x

Growth & revenue

Revenue Growth TTM

ELUT

-48.8%

MGX

-50.7%

Forward Revenue Growth

MGX

30.0%

ELUT

-42.7%

Profitability & performance

Gross Margin

ELUT

57.8%

MGX

0.0%

ROE

ELUT

253.3%

MGX

-5123.0%

FCF Yield %

ELUT

-126.5%

MGX

-227.9%

52-Week Performance

ELUT

-7.4%

MGX

-68.7%

Detailed metrics comparison

ELUT

Elutia Inc

MGX

Metagenomi Therapeutics Inc

Market Cap

ELUT$36M

MGX$38M

Enterprise Value

ELUT$16M

MGX$-1M

Price

ELUT$0.82

MGX$1.00

P/E Ratio

ELUT0.70x

MGXN/A

P/S Ratio

ELUT3.00x

MGX2.72x

EV/Sales

ELUT1.36x

MGX-0.10x

EV/EBITDA

ELUT0.00x

MGX0.00x

P/B Ratio

ELUT2.19x

MGX0.34x

P/FCF Ratio

ELUTN/A

MGXN/A

EV/FCF

ELUT-0.36x

MGX0.02x

PEG Ratio

ELUTN/A

MGXN/A

Forward P/E (NTM)

ELUTN/A

MGXN/A

Forward P/S (NTM)

ELUTN/A

MGX3.83x

Revenue (TTM)

ELUT$12M

MGX$14M

Revenue Growth (YoY)

ELUT-48.8%

MGX-50.7%

Forward Rev Growth

ELUT-42.7%

MGX30.0%

Gross Margin (TTM)

ELUT57.8%

MGX0.0%

Operating Margin (TTM)

ELUT0.0%

MGX0.0%

EBITDA Margin (TTM)

ELUT-163.0%

MGX-491.3%

Net Margin (TTM)

ELUT426.9%

MGX-477.5%

FCF Margin (TTM)

ELUT-379.3%

MGX-620.9%

Net Income (TTM)

ELUT$52M

MGX$-66M

FCF (TTM)

ELUT$-46M

MGX$-86M

EPS (TTM)

ELUT$1.17

MGX$0.00

ROE (TTM)

ELUT253.3%

MGX-5123.0%

ROA (TTM)

ELUT108.7%

MGX-3662.0%

ROIC (TTM)

ELUT253.3%

MGX-5123.0%

Cash

ELUT$20M

MGX$39M

Debt

ELUT$0

MGX$0

Net Cash/Debt

ELUT$20M

MGX$39M

Current Ratio (TTM)

ELUT1.77x

MGX4.50x

Quick Ratio (TTM)

ELUT1.58x

MGX4.37x

Debt/Equity (TTM)

ELUT0.00x

MGX0.00x

Debt/Assets (TTM)

ELUT0.0%

MGX0.0%

Interest Coverage (TTM)

ELUTN/A

MGXN/A

Net Debt/EBITDA (TTM)

ELUT0.00x

MGX0.00x

Beta

ELUT0.97

MGX0.68

52W Performance

ELUT-7.4%

MGX-68.7%

YTD Performance

ELUT28.0%

MGX-40.1%

% from 52W High

ELUT-40.6%

MGX-74.7%

% from 52W Low

ELUT64.6%

MGX4.2%

Asset Turnover (TTM)

ELUT0.25x

MGX0.10x

FCF Yield (TTM)

ELUT-126.5%

MGX-227.9%

Earnings Yield (TTM)

ELUT142.4%

MGX-175.2%

Dividend Yield (TTM)

ELUTN/A

MGXN/A

Rule of 40

ELUT-428.1

MGX-671.6

EV/GP/RG

ELUTN/A

MGXN/A

Ticker research

View ELUT research View MGX research

Metric	ELUT Elutia Inc	MGX Metagenomi Therapeutics Inc
Market & Valuation
Market Cap	$36M	$38M
Enterprise Value	$16M	$-1M
Price	$0.82	$1.00
P/E Ratio	0.70x	N/A
P/S Ratio	3.00x	2.72x
EV/Sales	1.36x	-0.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.19x	0.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.36x	0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.83x
Revenue & Growth
Revenue (TTM)	$12M	$14M
Revenue Growth (YoY)	-48.8%	-50.7%
Forward Rev Growth	-42.7%	30.0%
Profitability
Gross Margin (TTM)	57.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-163.0%	-491.3%
Net Margin (TTM)	426.9%	-477.5%
FCF Margin (TTM)	-379.3%	-620.9%
Net Income (TTM)	$52M	$-66M
FCF (TTM)	$-46M	$-86M
EPS (TTM)	$1.17	$0.00
ROE (TTM)	253.3%	-5123.0%
ROA (TTM)	108.7%	-3662.0%
ROIC (TTM)	253.3%	-5123.0%
Financial Health
Cash	$20M	$39M
Debt	$0	$0
Net Cash/Debt	$20M	$39M
Current Ratio (TTM)	1.77x	4.50x
Quick Ratio (TTM)	1.58x	4.37x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	0.68
52W Performance	-7.4%	-68.7%
YTD Performance	28.0%	-40.1%
% from 52W High	-40.6%	-74.7%
% from 52W Low	64.6%	4.2%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.10x
FCF Yield (TTM)	-126.5%	-227.9%
Earnings Yield (TTM)	142.4%	-175.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-428.1	-671.6
EV/GP/RG	N/A	N/A
Ticker research	View ELUT research	View MGX research